

MEDvidi is a popular GLP-1 medication provider offering both semaglutide and tirzepatide for weight loss. With a 7.5/10 rating, MEDvidi maintains a strong reputation in the telemedicine industry. With a monthly price of $195, MEDvidi positions itself as a mid-range provider in the competitive GLP-1 market.
The platform provides accessible GLP-1 medications through an online platform. Offering both MEDvidi tirzepatide and semaglutide as part of their MEDvidi GLP-1 medication program gives patients and their healthcare providers flexibility to choose the best treatment based on individual needs and response. Whether you've been researching MEDvidi reviews, MEDvidi reviews complaints, or asking "is MEDvidi legit," you'll find that MEDvidi delivers legitimate, high-quality telemedicine services with licensed healthcare providers.
MEDvidi does not publish a customer phone number on its website; support runs through your account, not published. MEDvidi operates with full transparency, HIPAA compliance, and a commitment to helping patients achieve their weight loss goals safely and effectively.
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
None. The site states no membership or hidden fees.
Introductory consultation $195. Introductory plus follow-up package $249 (a $105 saving). Follow-up consultation $159. Medication is not included in any of these figures.
Price of the introductory consultation. Follow-ups are $159 and medication is not included.
The $195 figure is what MEDvidi charges for the visit itself, not for a month of treatment. Because the medication is billed separately, this number cannot be compared directly against providers that quote one all-in monthly price - your real monthly cost depends on what you end up paying for the drug.
Fill out a comprehensive medical questionnaire about your health history, weight loss goals, and current medications.
A licensed healthcare provider reviews your information and determines if GLP-1 medication is right for you.
Your prescription is shipped directly to your door with clear instructions and ongoing support.
What follows is what MEDvidi states on its own website. Where the company does not publish an answer, we say so rather than assume the industry norm applies.
Not stated. MEDvidi says a provider will prescribe a GLP-1 if appropriate but does not specify brand-name or compounded product on its weight-loss page.
Assessed during a comprehensive online health assessment at the introductory consultation. A BMI calculator is offered as a starting point.
A booked consultation with a provider who performs a comprehensive health assessment, produces a personalised treatment plan and prescribes a GLP-1 if appropriate, with follow-up visits to track progress and adjust the plan.
Not stated as a requirement.
Not described.
Not applicable
Follow-up consultations, treatment-plan adjustment, insurance coverage assistance
Semaglutide (brand names Wegovy and Ozempic) is a GLP-1 receptor agonist that has been shown to help people lose an average of 15% of their body weight. It works by reducing appetite, slowing digestion, and helping you feel full longer.
Tirzepatide (brand names Mounjaro and Zepbound) is a dual GIP/GLP-1 receptor agonist that has demonstrated even more significant weight loss results, with clinical trials showing an average of 20% body weight reduction. It offers a dual-action approach to weight management.
MEDvidi is particularly well-suited for:
Not published on the weight-loss page
Contact form on site
Not available
Not published
None published
Appointment-based; no subscription described
Not published
MEDvidi is a cash-pay service and does not bill insurance. Not stated. Telehealth consultations are normally HSA/FSA eligible - check with your plan.
Yes, MEDvidi is a legitimate telemedicine provider offering GLP-1 medications for weight loss. MEDvidi operates with licensed healthcare providers and follows all regulatory requirements for prescribing and dispensing medications. With a 7.5/10 rating, MEDvidi maintains a solid reputation in the telemedicine industry.
Many people ask "is MEDvidi legitimate?" or "is MEDvidi a scam?" - these concerns are natural when considering online healthcare services. However, MEDvidi is a fully legitimate medical service that employs licensed physicians, maintains HIPAA compliance, and dispenses authentic FDA-approved medications.
MEDvidi offers both semaglutide and tirzepatide (MEDvidi tirzepatide is available as part of their comprehensive GLP-1 medication program). MEDvidi GLP-1 medications include:
Both MEDvidi GLP-1 options are available at the competitive price of $195/month, making them accessible for most patients seeking weight loss treatment.
You can reach MEDvidi through multiple channels:
The MEDvidi customer support team is available Not published to answer your questions about their GLP-1 weight loss programs.
Assessed during a comprehensive online health assessment at the introductory consultation. A BMI calculator is offered as a starting point.
Not stated as a requirement.
Not stated. MEDvidi says a provider will prescribe a GLP-1 if appropriate but does not specify brand-name or compounded product on its weight-loss page.
Not described.
Introductory consultation $195. Introductory plus follow-up package $249 (a $105 saving). Follow-up consultation $159. Medication is not included in any of these figures. Membership fee: None. The site states no membership or hidden fees.
Not published
Not stated. Telehealth consultations are normally HSA/FSA eligible - check with your plan.
When researching "MEDvidi reviews," it's important to look at multiple sources. Here's what we found about MEDvidi reviews and complaints:
MEDvidi has earned a solid 7.5/10 rating based on pricing, service quality, medication options, and customer support. This places MEDvidi among the well-rated GLP-1 providers in the market.
Like any healthcare provider, some customers search for "MEDvidi reviews complaints" or "MEDvidi reviews and complaints" to understand potential issues. While MEDvidi maintains a strong reputation, here's what to know:
When searching for "MEDvidi reviews Consumer Reports" or "MEDvidi reviews consumer reports complaints," remember that independent review platforms provide valuable insights. MEDvidi's rating of 7.5/10 reflects consistent customer feedback across multiple evaluation criteria.
Whether you're searching for "MEDvidi reviews" or "MEDvidi reviews complaints," our comprehensive analysis shows that MEDvidi delivers on its promises of high-quality GLP-1 weight loss medication with solid customer support.
If MEDvidi is not the right fit, these providers are the closest comparisons on medication and price. Each links to its own review, or you can put the two side by side.
A consultation service only. There is no medication pricing, no fulfilment and no ongoing programme wrapped around the prescription.
See how MEDvidi ranks
See how MEDvidi ranks
See how MEDvidi ranks
What the trials actually showed, how the two drugs differ, and which one suits which patient.
What compounded actually means, why the price gap has narrowed, and the questions to ask first.
Every pricing model in the market, decoded - and why the advertised number is rarely the real one.
The BMI thresholds, the contraindications that rule people out, and what providers actually check.
This review is editorial research, not medical advice. GLP-1 medications are prescription drugs with real risks and contraindications, and nothing here should be used to decide whether to start, stop or change a treatment. Only a licensed clinician who knows your history can tell you whether MEDvidi - or any GLP-1 medication - is appropriate for you. If you think you are having a serious reaction to a medication, contact a healthcare professional or emergency services.
Prices, policies and medication availability change often in this market. We report what MEDvidi published on its own site at the time of review; confirm the current terms with the provider before you buy.